(Q68132929)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

1 reference

C K Osborne

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

B A Blumenstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

E D Crawford

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

G R Weiss

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

R M Bukowski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

N R Larrimer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

477-478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

The chemotherapy of prostatic adenocarcinoma

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980080-2

7 January 2021

A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980080-2

7 January 2021

Treatment of advanced carcinoma of the prostate (stage D) with infusion of cis-diamminedichloroplatinum (II NSC 119875): a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980080-2

7 January 2021

Comparison of Estramustine Phosphate, Methotrexate and cis-Platinum: in Patients with Advanced1 Hormone Refractory Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980080-2

7 January 2021

Therapeutic activity of mitoxantrone and ametantrone against murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980080-2

7 January 2021

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980080-2

7 January 2021

Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980080-2

7 January 2021

10.1016/S0959-8049(05)80080-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591066%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference